SRT-100™ Locator

See and treat with the SRT-100 Vision™.

For patients and physicians who want the ultimate in advanced Superficial Radiation Therapy technology, Sensus Healthcare offers the SRT-100 Vision™—the next generation of innovation in our powerful arsenal against non-melanoma skin cancer and unsightly keloid scarring.

Built with all the same great features and remarkable efficacy that distinguish the original SRT-100™, the SRT-100 Vision™ delivers the precise, painless calibrated dose of Superficial Radiation Therapy patients and physicians expect, but offers additional features—most notably high-frequency ultrasound for imaging.

With a high-frequency ultra-sound guidance system, the SRT-100 Vision™ allows physicians to view areas being treated while they are being treated. This “see and treat” capability allows basal and squamous cell carcinomas, as well as keloid tissue, to be assessed more thoroughly so treatment can be targeted more precisely. When the ultrasound technology is placed over the treatment area using the laser positioning system, physicians can assess the lesion to see how deep it is and fine tune the exact amount of radiation needed. This will ultimately help tailor each patient’s treatment protocol when physicians are able to see how the lesion is progressing with each treatment session. Not only this, but each treatment session is recorded for patient records with the LesionCam™.

The SRT-100 Vision™ offers physicians, institutions and healthcare systems great value on several levels. This compact, efficient and very effective mobile device makes it easy to serve new patients and more patients. By increasing patient volume, the SRT-100 Vision™ allows care providers to expand their reputation and footprint in the community. And by adding a non-surgical treatment option that delivers a 95+ percent cure rate for non-melanoma cancer, along with a 90+ percent cure rate for keloid scarring, the SRT-100 Vision™ helps reduce the overall cost of healthcare.

With a frequency of 22 MHz, treatment boundaries and margins can be better defined. In turn, better definition helps guide physicians with decisions about optimal treatment energy and applicator size.

srt-100-vision-machine-747x1024

In addition to the high-frequency ultrasound image guidance system, other enhancements include:

The SRT-100 Vision™ has many unique features that make treatment safe, comfortable and effective for patients and physicians.

laser-positioning

Laser positioning
system

For precise beam port
positioning and re-positioning
on the treatment area

digital-camera

LesionCam™

Provides lesion
photo-registration and a
video of treatment for
patient records

touch-screen

Touch-screen control
console and control
module

Facilitate the set up, initiation,
monitoring and termination of
exposures. The module can be
located remotely.

audio-visual

Audio/visual monitor

Provides constant
bi-directional patient
communication

ai-filter

Automatic Al and CU filter
magazine

Applies the correct filter to
match the selected energy and
beam depth

electronic-records

Electronic medical
records (EMR), HL7 and
PDF record and report
export

Organizes patient scheduling and
record management to optimize
workflow

treament-planning

Dosimetry – Record and Verify

Calculates proper dosing and
measures each dose
administered during
treatment to ensure patient
safety and optimal outcomes

radcheck

RADCheck™ QC

Automatically confirms system
calibration each time the system
is initiated to ensure the patient
is receiving the correct dose and
eliminates the need for
un-scheduled calibrations

Finally, dermatologists, radiation oncologists, hospitals, and other care facilities can provide their patients with a non-surgical treatment option that delivers remarkable cure rates while preserving healthy tissue. The innovative SRT-100 Vision™ delivers 95 + percent cure rates while eliminating aspects of treatment that often cause anxiety, slow healing and recovery, and leave patients with embarrassing scarring.

Like the SRT-100™, the SRT-100 Vision™ has been cleared by the U.S. Food and Drug Administration for the treatment of non-melanoma skin cancer and keloids. It is ideal for private dermatology and oncology practices, as well as hospitals and healthcare providers with one or more location.

 

Contact Us to Receive the SRT-100 Vision Brochure

General contact

Please wait...

Sensus reserves the right to modify or change the design of the products at any given time without notice as technology and client needs evolve over time.

srt-100-vision-section-4-machine-695x1024
icon-knife

No Cutting

icon-human

No Pain

icon-clock

No Downtime

icon-head

No Scarring